Lund et al. assess whether levels of neurofilament light chain in the plasma can be used to monitor development of cerebral disease in people with adrenoleukodystrophy (ALD). Levels of plasma neurofilament light levels in the blood predicted cerebral disease onset in 5 boys with ALD.
- Troy C. Lund
- Ashish O. Gupta
- Paul J. Orchard